Ticker Details
Structure Therapeutics Inc.
IPO Date:	February 3, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.5B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.41 | 3.69%
Avg Daily Range (30 D):	$1.31 | 2.59%
Avg Daily Range (90 D):	$1.43 | 3.12%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	.49M
Avg Daily Volume (90 D):	.66M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	2,446
Avg Institutional Trade:	$1.79M
Avg Institutional Trade (30 D):	$3.09M
Avg Institutional Trade (90 D):	$2.3M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2M
Avg Closing Trade (30 D):	$2.06M
Avg Closing Trade (90 D):	$2.38M
Avg Closing Volume:	47.97K

News

May 17, 2026 @ 6:22 PM This Obesity Drug Stock Has Jumped 60% as Phase 3 ... Source: Jonathan Ponciano

Mar 16, 2026 @ 11:00 AM Structure Therapeutics Reports Positive Topline Da... Source: Structure Therapeutics Inc.

Feb 26, 2026 @ 6:35 PM PatentVest Releases New Report on The Oral Small-M... Source: Patentvest

Jan 23, 2026 @ 2:18 PM Weight Loss Drugs Market Is Crowded But Structure ... Source: Vandana Singh

Jan 13, 2026 @ 7:33 PM A 10% Owner Of Structure Therapeutics Shed Shares Source: Adé Hennis

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.01	$-.49	$-.35
Diluted EPS	$-1.01	$-.49	$-.35
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-214.84M	$-106.16M	$-75.97M
Operating Income / Loss	$-257.81M	$-118.63M	$-89.38M
Cost of Revenue
Net Cash Flow	$125.61M	$-43.53M	$-483.46M
PE Ratio